Copyright
©The Author(s) 2023.
World J Clin Cases. Jul 6, 2023; 11(19): 4601-4611
Published online Jul 6, 2023. doi: 10.12998/wjcc.v11.i19.4601
Published online Jul 6, 2023. doi: 10.12998/wjcc.v11.i19.4601
Table 4 Comparison of safety evaluation, and postoperative hospital stays and costs, n (%)
| UTI (n = 91) | Placebo (n = 90) | P value | |
| Granulocytopenia | 8 (8.79) | 4 (4.44) | 0.240 |
| Abnormal liver enzymes | 31 (34.07) | 25 (27.77) | 0.360 |
| Diarrhea | 27 (29.67) | 18 (20.00) | 0.132 |
| Vomiting | 19 (20.88) | 11 (12.22) | 0.117 |
| Allergies | 22 (24.18) | 9 (10.00) | 0.029 |
| Hospitalization stays, day, mean ± SD | 17.8 ± 4.2 | 19.6 ± 5.3 | 0.012 |
| Hospitalization costs, CNY, mean ± SD | 3.94 ± 0.82 | 3.82 ± 0.99 | 0.376 |
- Citation: Wang SQ, Jiao W, Zhang J, Zhang JF, Tao YN, Jiang Q, Yu F. Ulinastatin in the treatment of severe acute pancreatitis: A single-center randomized controlled trial. World J Clin Cases 2023; 11(19): 4601-4611
- URL: https://www.wjgnet.com/2307-8960/full/v11/i19/4601.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i19.4601